TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2018

Phase II open label pilot trial of aprepitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic FOLFOX chemotherapy for the treatment of colorectal cancer.

Joseph S Bubalo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.